CLINICAL_TRIALS
trial_result
· 2025-01-22
Clinical Trial Update: Phase Ib Clinical Study of Keynatinib [Phase 1]
Summary
A Phase Ib study of Keynatinib for B-cell lymphoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medolution Ltd. | Conditions: Lymphoma, B-Cell | Phase 1 | Status: RECRUITING